Christopher J Sobecki Ww International, Inc. (WW) insider trading activity

Christopher J Sobecki is Director of WW INTERNATIONAL, INC.. Currently has a direct ownership of 109,954 shares of WW, which is worth approximately $82,465. The most recent transaction as insider was on May 31, 2023, when has been sold 2,053 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K

0% 3M change

0% 12M change

Total Value Held $82,465

CHRISTOPHER J SOBECKI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2023	BUY Exercise of conversion of derivative security	-	2,053 Added 1.83%	109,954 Common Stock
May 31 2023	BUY Grant, award, or other acquisition	-	1,353 Added 1.24%	107,901 Common Stock
Jan 02 2023	BUY Grant, award, or other acquisition	-	5,067 Added 4.54%	106,548 Common Stock
Nov 17 2022	BUY Open market or private purchase	$125,100 $4.17 p/Share	30,000 Added 22.82%	101,481 Common Stock
Oct 03 2022	BUY Grant, award, or other acquisition	-	4,595 Added 6.04%	71,481 Common Stock
Jul 04 2022	BUY Grant, award, or other acquisition	-	2,745 Added 3.94%	66,886 Common Stock
Apr 04 2022	BUY Grant, award, or other acquisition	-	1,797 Added 2.73%	64,141 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	$18,746 $15.9 p/Share	1,179 Added 1.86%	62,344 Common Stock
Oct 04 2021	BUY Grant, award, or other acquisition	$18,742 $18.78 p/Share	998 Added 1.61%	61,165 Common Stock
Jul 05 2021	BUY Grant, award, or other acquisition	$18,744 $35.84 p/Share	523 Added 0.86%	60,167 Common Stock
Apr 05 2021	BUY Grant, award, or other acquisition	$18,739 $30.77 p/Share	609 Added 1.01%	59,644 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	724 Added 1.21%	59,035 Common Stock
Sep 28 2020	BUY Grant, award, or other acquisition	-	996 Added 1.68%	58,311 Common Stock

Also insider at

LXRX

LEXICON PHARMACEUTICALS, INC. Healthcare

Director

CJS